Officer sold ~$204K of Intuitive Surgical
Scheduled in advanceISRG · NASDAQ · Health Care Equipment
Health Care Equipment company based in Sunnyvale, California.
Last close, Oct 1, 2026
$401.24
Adjusted for splits and dividends
Last 12 months
-8.4%
S&P 500 +14.3% over the same dates
Market value
$142B
Last close × shares outstanding
Bets against the stock: 8.12M shares sold short (2.3% of shares outstanding), +5.0% vs the previous count, 3.4 days of normal trading to buy them back. FINRA, as of Sep 15, 2026.
Insiders buying, last 90 days
None
No open-market purchases reported
Insiders selling, last 90 days
20 sales
$4.98M sold. Insiders sell for many reasons.
New federal contracts, 12 months
None
Nothing found for this company
Revenue, fiscal 2025
$10.1B
+20.5% vs the year before
Net income, fiscal 2025
$2.86B
As reported in the annual filing
Shares outstanding
353M
As of Jul 16, 2026
In fiscal 2025 the company spent $2.3B buying back its own shares. Cash actually paid, from its cash-flow statement.
Officer sold ~$204K of Intuitive Surgical
Scheduled in advanceOfficer sold ~$203K of Intuitive Surgical
Scheduled in advanceOfficer plans to sell ~$823K of Intuitive Surgical
Planned, from payOfficer sold ~$9.1K of Intuitive Surgical
Scheduled in advancePrices are daily closes from Polygon.io. Company figures come from its own SEC filings. Past moves are not a forecast. OQRO reports what was filed and never tells you what to buy or sell.
Short sale volume: 56.5% of the volume reported to FINRA over the last 20 trading days was marked short, above its 1-year average of 42.1%. FINRA daily files, to Oct 2, 2026.
Short sale volume is not short interest. It counts trades marked short, including market makers selling short to fill buy orders, so it is a share of daily trading, not a count of bets against the stock.
1 notice filed with state agencies, covering 331 workers in total. Employers must warn the state ahead of a plant closing or mass layoff at a site.
Official WARN lists from California, Texas, New York, Florida, Illinois and Washington only; notices filed in other states are not shown. Matched on the employer name as filed, so a notice filed under an unrelated subsidiary name can be missing. Dates are the notice date (Washington: the date the state received it).
105 certified in FY2026 Q3, vs 117 a year earlier. 105 positions in total, median offered wage $167K a year.
Labor condition applications for H-1B workers certified by the Department of Labor, counted by decision date (FY2026 Q3: Apr 1, 2026 to Jun 30, 2026, the latest quarter published). A certified application is a step before a visa petition, not a hire or a visa, and one application can cover several positions. Matched by employer ID number or name.
12 approvals or clearances and 15 recalls recorded by the FDA for this company and its listed subsidiaries.
From openFDA: Drugs@FDA (new applications and new uses), device 510(k) and PMA decisions, and FDA enforcement reports. Class I recalls are the most serious, Class III the least. Most recalls are started by the company itself. Labeling and manufacturing changes are not listed.
Last 12 months, adjusted daily closes
Adjusted close went from $438.04 on Oct 1, 2025 to $401.24 on Oct 1, 2026 (-8.4%). Disclosed trades in the last 12 months: 0 insider purchases, 83 insider sales (83 under pre-arranged plans), 5 Congress purchases, 0 Congress sales.